<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03999320</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL18_0043</org_study_id>
    <secondary_id>UF7590</secondary_id>
    <nct_id>NCT03999320</nct_id>
  </id_info>
  <brief_title>Sophrology and Congenital Heart Disease</brief_title>
  <acronym>SOPHRO CARE</acronym>
  <official_title>Impact of Sophrology on Exercise Capacity of Adolescents and Young Adults With Congenital Heart Disease : Multicenter Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The SOPHRO-CARE trial aims to measure the impact of sophrology on exercise capacity of
      adolescents and young adults with congenital heart disease.

      Investigator hypothesized that a series of group sessions of sophrology may improve the
      exercise capacity, in this population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Adolescents and adults with congenital heart disease (CHD) have reduced exercise capacity
      compared to the general population.

      Our recent randomized trial in a population of children and adolescents with asthma showed
      that sophrology improve lung function (NCT02114398). Sophrology, from the Greek &quot;study of
      consciousness in harmony&quot;, is an adjuvant therapy, considered in healthcare as a relaxation
      technique, mainly based on breathing.

      Investigator assume that adolescents and young adults (13-25 y.o.) with CHD who participate
      in a program of sophrology with structured group sessions will improve their exercise
      capacity as measured by the maximum oxygen uptake (VO2max), in comparison with a control
      group.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 19, 2019</start_date>
  <completion_date type="Anticipated">August 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maximum oxygen uptake (VO2 max)</measure>
    <time_frame>Variation between Baseline (M0) and at 12 months (M12)</time_frame>
    <description>VO2max Variation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life score</measure>
    <time_frame>Evolution of the PedsQL 4.0 self-reported scores from month 0 to month 12</time_frame>
    <description>Quality of life score variation (PedsQL, 24 items), range score from 0 to 100, higher score indicating better quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity score</measure>
    <time_frame>Variation between Baseline (M0) and at 12 months (M12)</time_frame>
    <description>Score of physical activity (Ricci and Gagnon questionnaire, 9 items, total range score from 6 to 45, higher score indicating a higher level of physical activity)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Congenital Heart Disease</condition>
  <arm_group>
    <arm_group_label>Sophrology group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>8 sophrology sessions, approximately 60 minutes each, spread over 12 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>usual care</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sophrology sessions</intervention_name>
    <description>8 sophrology sessions, approximately 60 minutes each, spread over 12 months</description>
    <arm_group_label>Sophrology group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>usual care</intervention_name>
    <description>usual care</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient aged 13 to 25 years old

          -  With a congenital heart disease (CHD) as defined in the international anatomic and
             clinical classification (ACC) - CHD classification.

          -  Informed consent from adult patients or parents/legal guardians for minor patients

        Exclusion Criteria:

          -  Medical contraindication to perform an exercise test.

          -  Patient already included in a clinical trial.

          -  Cardiac surgery planned during the study

          -  Severe intellectual disability that does not allow practice of sophrology exercise or
             questionnaires to be completed .
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pascal AMEDRO, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UH Montpellier</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sophie GUILLAUMONT, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saint Pierre Institut</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yves DULAC, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UH Toulouse</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Damien BONNET, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>APHP Necker</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pascal AMEDRO, MD</last_name>
    <phone>0467336632</phone>
    <email>p-amedro@chu-montpellier.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Huguette ROMIEU</last_name>
    <email>huguette.romieu@wanadoo.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Arnaud de Villeneuve</name>
      <address>
        <city>Montpellier</city>
        <state>Occitanie</state>
        <zip>34090</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pascal AMEDRO, PhD</last_name>
      <phone>+33 (0) 4 67 33 66 39</phone>
      <email>p-amedro@chu-montpellier.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://creativecommons.org/licenses/by/4.0/</url>
    <description>Impact of Sophrology on cardiopulmonary fitness in teenagers and</description>
  </link>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>June 24, 2019</study_first_submitted>
  <study_first_submitted_qc>June 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 26, 2019</study_first_posted>
  <last_update_submitted>March 4, 2020</last_update_submitted>
  <last_update_submitted_qc>March 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

